🧫 Experiment Protocol
ExploratoryDiabetesPPARγ2, Tug (Aspscr1)Cell culture and/or biochemical assaysproposed
Investigation of how the PPARγ2 Pro12Ala polymorphism, which is associated with reduced diabetes risk in humans, affects the binding interaction with the TUG C-terminal product. This study provided mechanistic insight into how a protective genetic variant might enhance the metabolic benefits of the TUG cleavage pathway.
PRIMARY OUTCOME
Binding affinity between TUG product and PPARγ variants
EXPECTED OUTCOMES
Enhanced binding of TUG product to Pro12Ala variant compared to wild-type
SUCCESS CRITERIA
Measurable increase in binding affinity for the protective variant
PROTOCOL
Protein-protein interaction assays, binding studies with wild-type and variant PPARγ2